3D Analyst - Cardiac Imaging
Elucid
Summary
Transform cardiac imaging into life-changing insights as part of our expert CT Analysis team. At Elucid, our CT analysis team transforms complex cardiac imaging data (CCTA) into precise 3D arterial models. The ideal candidate leverages a background in radiology and experience with cardiac CTA post-processing software to deliver a product that directly impacts patient care. Working at the intersection of medical imaging and advanced computational modeling, our analysts collaborate closely with clinical, engineering, and quality teams to produce accurate, timely results that enable physicians to prevent and treat cardiovascular disease.
Job description
The ideal candidate will have:
- Associate or Bachelor's degree with 3+ years of work experience.
- Academic, clinical, and/or industry experience with cardiovascular imaging or cardiac CTA post-processing software preferred.
- ARRT (R)(CT) or cardiac CT experience preferred.
- Computer savvy and willing to learn new technologies; proficient in Microsoft Office Suite.
- Excellent written and verbal communication.
Work Hours, Location & Travel Requirements:
- To best support our customers across time zones, we have team members who begin their work week or work day at a variety of different times/days (including weekends and holidays as needed). Identify your schedule preference when applying for the job.
- For all positions, initial onboarding and training is conducted beginning at 9:00 AM EST for a 10-12 week period.
- Occasional travel to the Boston office is required for non-local hires, including the first 1-2 weeks of hands-on training.
Requirements
- Associate or Bachelor's degree with 3+ years of work experience
- Academic, clinical, and/or industry experience with cardiovascular imaging or cardiac CTA post-processing software preferred
- ARRT (R)(CT) or cardiac CT experience preferred
- Computer savvy and willing to learn new technologies
- Proficient in Microsoft Office Suite
- Excellent written and verbal communication
Benefits
- Flexible hybrid environment
- Office days Mondays and Wednesdays
Company overview
Elucid is a Boston-based medical technology company founded in 2013 that specializes in developing AI-powered imaging analysis software for cardiovascular disease assessment. The company's flagship product, PlaqueIQ, is the only FDA-cleared computed tomography angiography (CTA) algorithm that objectively quantifies plaque morphology validated against tens of thousands of tissue annotations by renowned pathologists. Elucid's technology brings precision patient care from oncology to cardiology by providing physicians with critical information for assessing the risk of plaque rupture in arteries that can lead to heart attack and stroke. The company's software is designed to understand the root cause of cardiovascular disease deeply, offering objective and quantitative assessment of arterial plaque validated by histology. Elucid has raised over $150 million in funding and is pursuing an indication for FFRCT (fractional flow reserve derived from CT), uniquely derived from its PlaqueIQ technology, to measure coronary blockages non-invasively. The company's solutions are available for commercial use in the U.S., UK, EU, and South Korea, and recently gained broad CMS reimbursement for coronary plaque analysis using PlaqueIQ.